Conconi Maria Teresa, Spinazzi Raffaella, Nussdorfer Gastone G
Department of Pharmaceutical Sciences, School of Pharmacy, University of Padua, I-35121 Padua, Italy.
Int Rev Cytol. 2006;249:1-51. doi: 10.1016/S0074-7696(06)49001-X.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are the main endogenous ligands of a class of G protein-coupled receptors (Rs). Three subtypes of PACAP/VIP Rs have been identified and named PAC(1)-Rs, VPAC(1)-Rs, and VPAC(2)-Rs. The PAC(1)-R almost exclusively binds PACAP, while the other two subtypes bind with about equal efficiency VIP and PACAP. VIP, PACAP, and their receptors are widely distributed in the body tissues, including the adrenal gland. VIP and PACAP are synthesized in adrenomedullary chromaffin cells, and are released in the adrenal cortex and medulla by VIPergic and PACAPergic nerve fibers. PAC(1)-Rs are almost exclusively present in the adrenal medulla, while VPAC(1)-Rs and VPAC(2)-Rs are expressed in both the adrenal cortex and medulla. Evidence indicates that VIP and PACAP, acting via VPAC(1)-Rs and VPAC(2)-Rs coupled to adenylate cyclase (AC)- and phospholipase C (PLC)-dependent cascades, stimulate aldosterone secretion from zona glomerulosa (ZG) cells. There is also proof that they can also enhance aldosterone secretion indirectly, by eliciting the release from medullary chromaffin cells of catecholamines and adrenocorticotropic hormone (ACTH), which in turn may act on the cortical cells in a paracrine manner. The involvement of VIP and PACAP in the regulation of glucocorticoid secretion from inner adrenocortical cells is doubtful and surely of minor relevance. VIP and PACAP stimulate the synthesis and release of adrenomedullary catecholamines, and all three subtypes of PACAP/VIP Rs mediate this effect, PAC(1)-Rs being coupled to AC, VPAC(1)-Rs to both AC and PLC, and VPAC(2)-Rs only to PLC. A privotal role in the catecholamine secretagogue action of VIP and PACAP is played by Ca(2+). VIP and PACAP may also modulate the growth of the adrenal cortex and medulla. The concentrations attained by VIP and PACAP in the blood rule out the possibility that they act as true circulating hormones. Conversely, their adrenal content is consistent with a local autocrine-paracrine mechanism of action.
血管活性肠肽(VIP)和垂体腺苷酸环化酶激活多肽(PACAP)是一类G蛋白偶联受体(Rs)的主要内源性配体。已鉴定出PACAP/VIP Rs的三种亚型,并命名为PAC(1)-Rs、VPAC(1)-Rs和VPAC(2)-Rs。PAC(1)-R几乎只与PACAP结合,而其他两种亚型与VIP和PACAP的结合效率大致相同。VIP、PACAP及其受体广泛分布于身体组织,包括肾上腺。VIP和PACAP在肾上腺髓质嗜铬细胞中合成,并由VIP能和PACAP能神经纤维释放到肾上腺皮质和髓质。PAC(1)-Rs几乎只存在于肾上腺髓质,而VPAC(1)-Rs和VPAC(2)-Rs在肾上腺皮质和髓质中均有表达。有证据表明,VIP和PACAP通过与腺苷酸环化酶(AC)和磷脂酶C(PLC)依赖性级联反应偶联的VPAC(1)-Rs和VPAC(2)-Rs,刺激肾小球带(ZG)细胞分泌醛固酮。也有证据表明,它们还可以通过引发髓质嗜铬细胞释放儿茶酚胺和促肾上腺皮质激素(ACTH)来间接增强醛固酮分泌,而儿茶酚胺和促肾上腺皮质激素反过来可能以旁分泌方式作用于皮质细胞。VIP和PACAP参与调节肾上腺皮质内层细胞糖皮质激素分泌的情况尚不确定,且肯定相关性较小。VIP和PACAP刺激肾上腺髓质儿茶酚胺的合成和释放,PACAP/VIP Rs的所有三种亚型都介导这种作用,PAC(1)-Rs与AC偶联,VPAC(1)-Rs与AC和PLC偶联,VPAC(2)-Rs仅与PLC偶联。Ca(2+)在VIP和PACAP的儿茶酚胺促分泌作用中起关键作用。VIP和PACAP也可能调节肾上腺皮质和髓质的生长。VIP和PACAP在血液中达到的浓度排除了它们作为真正循环激素发挥作用的可能性。相反,它们在肾上腺中的含量与局部自分泌-旁分泌作用机制一致。